Phase II Study to evaluate the response on two blocks of topotecan and carboplatin

Versions (1) ▾
  1. 12/9/13
Uploaded on:

December 9, 2013

No DOI assigned. To request one please log in.
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00130858 # Soft Tissue Sarcoma


  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion criteria
age < 21
Soft tissue sarcoma chemosensible, stage IV
measurable tumor lesions
Exclusion criteria
Lack of cooperation by the patient
no willingness of follow-up examinations
participation on another clinical trial at the same time
death due to the sickness within four weeks
Medical Concepts

Similar models